Joint venture partners Mission Street and investment manager BentallGreenOak (BGO) have signed the first tenant at Inventa, their newly completed purpose-built commercial science scheme in central Oxford. Biotechnology firm Nucleome Therapeutics has agreed to take 20,000 sq ft offitted labs and offices at the 65,000 sq ft building. Located at Botley Road, Inventa is the […]
Mission Street and BGO’s Inventa and Fabrica will be the first Sciences developments of a wider 2.5m sq ft pipeline of academic and commercial Science buildings creating the only Innovation District within walking distance of Oxford station and Oxford city’s world class academic, cultural and amenity offerings. https://oxfordwestend.co.uk/discover/
Artem Korolev discussed how to nurture and facilitate a world-class innovation system. https://www.youtube.com/watch?v=jL-16hnWVTw&list=PLRIcKUhnlDtg92I1zL24mHMkGHQLxb3tH&index=12&t=353s
Mission Street and BGO have secured a resolution to grant planning permission from Oxford City Council for Phase 2 of their development in the West End of Oxford. Known as Fabrica, the scheme will provide 180,000 sq ft of innovation real estate within a 10-minute walk from Oxford station and city centre. Designed by NBBJ, […]
Contractor 8build has secured the job to deliver the second phase of a 100,000 sq ft life sciences development in Cambridge. The Press biotech scheme is being developed by specialist investors Mission Street and BGO and will see lab and office space built either as a headquarters building or up to six smaller suites. This […]
Growing company has identified lack of space in sector hotspots According to the latest figures from DTRE, there’s nearly 900,000 sq ft of latent demand for life sciences space in Cambridge alone – and investment volumes have hit £139m in 2023 to date, with a further £88m under offer. Not bad for just one part of […]
